Daily Sabah logo

Politics
Diplomacy Legislation War On Terror EU Affairs Elections News Analysis
TÜRKİYE
Istanbul Education Investigations Minorities Expat Corner Diaspora
World
Mid-East Europe Americas Asia Pacific Africa Syrian Crisis Islamophobia
Business
Automotive Economy Energy Finance Tourism Tech Defense Transportation News Analysis
Lifestyle
Health Environment Travel Food Fashion Science Religion History Feature Expat Corner
Arts
Cinema Music Events Portrait Reviews Performing Arts
Sports
Football Basketball Motorsports Tennis
Opinion
Columns Op-Ed Reader's Corner Editorial
PHOTO GALLERY
JOBS ABOUT US RSS PRIVACY CONTACT US
© Turkuvaz Haberleşme ve Yayıncılık 2023

Daily Sabah logo

عربي
  • Politics
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • Elections
    • News Analysis
  • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Expat Corner
    • Diaspora
  • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • Islamophobia
  • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
  • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
  • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Reviews
    • Performing Arts
  • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
  • Gallery
  • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
  • TV
  • TÜRKİYE
  • Istanbul
  • Education
  • Investigations
  • Minorities
  • Expat Corner
  • Diaspora

Academic couple joins efforts for Turkey’s 1st mRNA vaccine 

by DAILY SABAH

ISTANBUL Jan 13, 2021 - 1:57 pm GMT+3
Ibrahim Halil Yıldırım (L) and Seval Cing Yıldırım (R) pose with their daughter Ayşe Damla, in Konya, central Turkey, Jan. 13, 2021. (AA Photo)
Ibrahim Halil Yıldırım (L) and Seval Cing Yıldırım (R) pose with their daughter Ayşe Damla, in Konya, central Turkey, Jan. 13, 2021. (AA Photo)
by DAILY SABAH Jan 13, 2021 1:57 pm

Two associate professors who left their university jobs to support the development of a vaccine against the coronavirus devote their time and energy to the race against time amid the outbreak

Ibrahim Halil Yıldırım and Seval Cing Yıldırım, two associate professors in Turkey, are following in the footsteps of Uğur Şahin and Özlem Türeci, the Turkish couple behind the Pfizer-BioNtech vaccine. As the coronavirus outbreak continues to claim lives in Turkey, the couple moved to the central province of Konya to join the research and development of the country’s first messenger RNA (mRNA) vaccine.

The couple, who worked at universities in the eastern province of Malatya and the southeastern province of Diyarbakır, moved to Konya seven months ago on a temporary assignment to work with their colleagues at Selçuk University. The coronavirus outbreak greatly changed their daily routine, and now they are confined to the laboratory most days in the race against time to develop a vaccine.

Seval Cing Yıldırım, who works in the Department of Biotechnology at Inönü University in Malatya, and her husband, a genetics expert at Dicle University, settled in Konya with their 11-year-old daughter Ayşe Damla to join the country’s locally made vaccine efforts. Ibrahim Halil Yıldırım says they were inspired by their colleagues who are sacrificing their time and labor for the vaccine.

“We are not here to do our best. We are here to carry out our responsibilities for this country. I discussed with my wife what we could do based on our expertise (to help fight against the outbreak) and thought joining vaccine research would be the best. I spoke to my parents and my daughter. They approved, and now we are here in Konya,” he said.

Being together in one city could have been a blessing for a couple used to working in different cities, but Yıldırım says it has one downside: not being able to see his daughter. “I see her less now. I have only two, sometimes one day off weekly and spend almost the entire day in the laboratory,” he told Anadolu Agency (AA) on Wednesday.

Seval Cing Yıldırım said they have been quite busy for months but her family does not complain. “Ayşe is used to seeing us work long hours. My mother also moved in with us for her care,” she said. “I only go home to eat and sleep. My husband sometimes does not come at all. We have little time to spend together."

Their daughter does not complain much, though she occasionally misses home. “I attend school and spend time with my grandmother and my cat. Of course, I want to go home but being in Konya is good too,” Ayşe Damla Yıldırım said.

Selçuk University is among a number of institutions working to develop vaccines against the coronavirus with local resources. Theirs will be the first mRNA vaccine, if approved. Scientists aim to have it ready for mass production by summer. Supported by the Scientific and Technological Research Council (TÜBITAK), the project is led by associate professor Nadir Koçak.

Koçak told AA on Monday that mRNA is known throughout the world as a third-generation vaccine technology. "One of our biggest goals was to bring this technology to our country," he said, adding that they started working on the vaccine nearly eight months after BioNTech-Pfizer and U.S. pharma company Moderna – and both teams have since rolled out their respective vaccines.

"Although this seems like a disadvantage, starting late has given us the opportunity to follow the latest publications on the viral protein in the world. We have seen formulas being used by leading organizations. We have moved toward developing a more stable, more effective vaccine," he explained.

He noted that they were working on a vaccine that could last for up to six months at room temperature, therefore eliminating the need for a cold chain. Koçak said their first mRNA vaccine was developed a month and a half ago and now they were heading toward the large stage in animal trials. He added that three different formulas of vaccines were devised by the experts and their syntheses were completed.

"We will start human trials within two months with the most effective one. We aim to create an effective and heat resistant vaccine. Our goal is to offer this vaccine to (the service of) humanity in the summer months," he said.

Noting that the phase studies were kept short due to the pandemic, Koçak said all vaccines received emergency use approval in the third phase. For now, a double dose of the vaccine will be administered two weeks apart, he said, adding that this proportion could change in the next two to three years.

MRNA vaccines work by stimulating cells to make a protein that triggers an immune response. That, in turn, produces antibodies that offer protection from diseases like COVID-19. The protein, called a “spike protein,” is actually part of the coronavirus but is harmless.

Researchers have been studying and working with mRNA vaccines for decades. Interest has grown in these vaccines because they can be developed in a laboratory using readily available materials. They have been previously studied for flu, Zika, rabies and cytomegalovirus (CMV).

  • shortlink copied
  • Last Update: Jan 13, 2021 4:10 pm
    RELATED TOPICS
    fight-against-terrorism DEUTSCHE-BANK US-LIBYA-RELATIONS
    KEYWORDS
    covid-19 outbreak vaccine mrna selçuk university konya
    The Daily Sabah Newsletter
    Keep up to date with what’s happening in Turkey, it’s region and the world.
    You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
    President Recep Tayyip Erdoğan (R) at a meeting with MHP leader Devlet Bahçeli, in the capital Ankara, Türkiye, March 20, 2023. (AA Photo)

    Erdoğan leads in possible 2nd round of Turkish elections: Survey

    Recep-Tayyip-Erdoğan
    A Turkish flag flies next to a NATO logo at the Alliance headquarters in Brussels, Belgium, Nov. 26, 2019. (Reuters Photo)

    Turkish Parliament set to debate Finland's NATO bid

    NATO-ACCESSION

    Türkiye reveals its 1st flying-wing unmanned fighter Anka-3

    Defense-industry

    Erdoğan slams opposition bloc for cooperating with pro-PKK HDP

    ELECTIONS
    No Image
    SOLOTÜRK makes demonstration flight in Tunisia
    PHOTOGALLERY
    • POLITICS
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • News Analysis
    • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Diaspora
    • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • İslamophobia
    • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
    • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
    • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Performing Arts
    • Reviews
    • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
    • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
    • Photo gallery
    • Jobs
    • privacy
    • about us
    • contact us
    • RSS
    © Turkuvaz Haberleşme ve Yayıncılık 2021